| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 29,596 | 33,138 | 23,198 | 16,869 | | Cost of Revenue | 23,464 | 26,510 | 18,875 | 15,192 | | | Gross Profit | 6,132 | 6,628 | 4,323 | 1,677 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 4,707 | 4,551 | 5,536 | 5,254 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,425 | 2,077 | (1,213) | (3,577) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (50) | (206) | 77 | 247 | | Earnings Before Interest And Taxes | 1,375 | 1,871 | (1,136) | (3,183) | | Interest Expense | 140 | 208 | 140 | 227 | | Income Before Tax | 1,235 | 1,663 | (1,276) | (3,410) | | Income Tax Expense | 333 | 501 | (388) | (1,150) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 902 | 1,162 | (888) | (2,260) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 902 | 1,162 | (888) | (2,260) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $902 | $1,162 | ($888) | ($2,260) |
|
0.11% Nasdaq 0.00%
Income Statement
